[ Price : $8.95]
BioMarin says it is discontinuing dosing and enrollment in portions of its mid-stage clinical program for Voxzogo (vosoritide) aft...[ Price : $8.95]
Integra LifeSciences recalls certain neurosurgical monitoring kits, citing potential safety risks linked to a needle component use...[ Price : $8.95]
FDA sends Japanese active pharmaceutical ingredient maker Alps Pharmaceutical a Form 483 from an inspection that identified multip...[ Price : $8.95]
Four stakeholders praise an FDA draft guidance on using Bayesian methods in clinical trial design and suggest ways to improve the ...[ Price : $8.95]
Two Akin attorneys review a 3/9 FDA draft guidance recommending ways in which it would like to see human and drug manufacturers re...[ Price : $8.95]
FDA sends Aldeyra a complete response letter for its investigational dry eye treatment reproxalap, concluding that the company fai...[ Price : $8.95]
FDA extends by three months its review of a Lantheus Holdings NDA for LNTH-2501, a diagnostic imaging agent targeting neuroendocri...[ Price : $8.95]
A group of U.S. senators is pressing HHS to reverse recent changes to FDA and other federal health Web sites, warning that altered...